News

Tuesday, 12 June 2012 - 23:03

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam

 
On 12 June 2012, The Treatment Action Campaign (TAC), SECTION27, Médecins Sans Frontières and Oxfam hosted a meeting prior to the launch of the 3rd SA TB Conference. The meeting brought together TB clinicians, counsellors, patients, activists and academics. Speakers and participants drew attention to the many challenges and failures of the country’s response to TB and DR TB, but also highlighted important...
Read more
Thursday, 7 June 2012 - 14:21

 

The Treatment Action Campaign’s (TAC) running team, Runners for Health, have successfully completed the 2012 Comrades Marathon. Seven of the runners finished the race in time to receive a medal - six managed to get bronze medals. Read what team members had to say about their experience of the marathon here.

  

 

...

Read more
Wednesday, 6 June 2012 - 11:26

A public lecture by Catherine Tomlinson, Senior Researcher for the Treatment Action Campaign and Mara Kardas-Nelson, Access and Innovation Officer for Médecins Sans Frontières

14 June 2012, 18:00 for 18:30
Barnard Fuller, Conference Room 4
University of Cape Town

 

...

Read more
Wednesday, 6 June 2012 - 11:18

The Treatment Action Campaign (TAC), Médecins Sans Frontières (MSF), SECTION27 and Oxfam will host a meeting on the morning of the launch of the 3rd SA TB Conference in Durban. The meeting will bring together community members, patients, activists, health care workers and government. The aim of the meeting is to examine challenges in reducing new cases of, and treating, tuberculosis (TB) and drug...

Read more
Tuesday, 29 May 2012 - 16:47

The Treatment Action Campaign (TAC), Médecins Sans Frontières (MSF), SECTION27 and Oxfam will host a meeting on the morning of the launch of the 3rd SA TB Conference. The meeting will bring together community members, patients, activists, health care workers and government. The aim of the meeting is to examine challenges in reducing new cases of, and treating, tuberculosis (TB) and drug resistant (DR) TB.

The first session will look at cost drivers of TB medicines and diagnostics that often act as barriers to access. We will examine the need for new and better medicines to treat DR...

Read more

Pages